Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569855 · ClinicalTrials.gov registry record · Phase 2
Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
A Phase 2 study of Cardiopulmonary Bypass and Open Heart Surgery, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 785
- Enrollment target
- 1
- Study location
NCT00569855: Completed Phase 2 study of Cardiopulmonary Bypass and Open Heart Surgery, sponsored by University of Arkansas.
NCT00569855 is a Phase 2 study of Cardiopulmonary Bypass and Open Heart Surgery that has completed, run by University of Arkansas. The registered enrollment target is 785 participants, above the 622-participant average among 10 other Cardiopulmonary Bypass trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00569855, a Phase 2 study of Cardiopulmonary Bypass and Open Heart Surgery, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 785 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiopulmonary bypass is done with a machine that does the work of the heart and lungs during open-heart surgery. This study is to determine if intravenous (i.v.) phenoxybenzamine is safe. This drug lowers the blood pressure, making it easier for the cardiopulmonary bypass machine to deliver blood and oxygen to all of the organs and tissues.
Primary Outcome
Number of subjects who required Norepinephrine \>0.1mcq/kg/min
Conditions Studied
Interventions
- DRUG Phenoxybenzamine
Study Locations (1)
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 785 participants |
| Start Date | 2001-02 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
What the finished NCT00569855 record still lists
NCT00569855 is an interventional study that assigns participants to a tested intervention. The registered 785 participants enrollment target is mid-sized for trials with a published cap, above the 622-participant average among 10 other Cardiopulmonary Bypass trials with a reported enrollment target (26% higher).
The record links to 2 conditions, with Cardiopulmonary Bypass appearing as the primary indexed condition, and to 1 intervention - of which Phenoxybenzamine is the first listed.
NCT00569855 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00569855 about?
NCT00569855 is a clinical study titled "Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery". Cardiopulmonary bypass is done with a machine that does the work of the heart and lungs during open-heart surgery. This study is to determine if intravenous (i.v.) phenoxybenzamine is safe. This drug lowers the blood pressure, making it easier for the cardiopulmonary bypass machine to deliver blood ...
What is the current status of trial NCT00569855?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 785 participants. The study started on 2001-02. Estimated completion is 2010-08.
What conditions does trial NCT00569855 study?
This clinical trial studies the following conditions: Cardiopulmonary Bypass, Open Heart Surgery.
What interventions are being tested in trial NCT00569855?
The interventions under investigation include: Phenoxybenzamine (DRUG).
Who is sponsoring clinical trial NCT00569855?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00569855 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary Bypass
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00569855's enrollment target sits among peer trials
785 2nd of 10 the highest of 10 other Cardiopulmonary Bypass trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiopulmonary Bypass trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
RECRUITING
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
-
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
ACTIVE NOT RECRUITING · Phase 3
-
Impact of Pulsatile Cardio-Pulmonary Bypass (CPB) on Vital Organ Recovery
ACTIVE NOT RECRUITING
-
SPY Imaging System: Its Role in Pediatric Cardiac Surgery
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06498128 · 785 participants
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
- NCT07276724 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- NCT07359846 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia